Loading…
Prostemics, a stem cell-based bio company, announced it will acquire 100% of OTKCNT, a cosmetic wet tissue manufacturer, from its largest shareholder Icure for 17 billion won (approximately US$14.3 million).
“We are going to double our overall sales by creating synergy with products that are applied with new technologies such as Exosomes.”businessreport.kr
Summarized from public sources; check the original articles before acting on it.